Feasibility of Prophylactic Haldol to Prevent Delirium in Cancer Patients
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This research study proposes to conduct an open label, feasibility study administering
prophylactic oral haldol to patients undergoing a hematopoietic stem cell transplant (HSCT).
The study will address the following research aims: 1) To demonstrate the feasibility of
enrolling HSCT patients in a prophylactic medication trial, 2) To determine the tolerability
of oral haldol in HSCT patients and 2) To compare rates of delirium in HSCT patients who
receive prophylactic haldol with an untreated historical control group.